Wintergerst E S, Jelk J, Asmis R
Institute of Biochemistry, University of Basel, Switzerland.
Histochem Cell Biol. 1998 Sep;110(3):231-41. doi: 10.1007/s004180050285.
Macrophages are key players in many aspects of human physiology and disease. It has been hypothesized that in a given microenvironment monocytes differentiate into specific subpopulations with distinct functions. In order to study the role of macrophage heterogeneity in atherogenesis, we established a novel isolation and culture technique for human monocyte-derived macrophages. The present technique does not select for monocyte subpopulations prior to the onset of differentiation. Monocytes were cultured for 2 weeks in the presence of autologous lymphocytes before being plated quantitatively. They differentiated into mature macrophages in terms of morphology, lipid composition, and biological activity. Based on phagocytic activity as well as on the expression of CD14, CD36, and the low-density lipoprotein (LDL) receptor, we have identified macrophage subpopulations that may play distinct roles in atherogenesis. While virtually all adherence-purified monocytes expressed CD14, CD36, and the LDL-R, we characterized three subpopulations of macrophages based on the expression of these antigens: CD36+CD14-LDL-R-(58+/-12%), CD36+CD14+LDL-R+(18+/-5%), the remaining cells being CD36-CD14- LDL-R-. The first two subsets decreased in size during further differentiation (51+/-12% and 8+/-3%, respectively). Our culture technique may also serve as a good model for studying the implications of macrophage heterogeneity in diseases other than atherosclerosis.
巨噬细胞在人类生理学和疾病的许多方面都起着关键作用。据推测,在特定的微环境中,单核细胞会分化为具有不同功能的特定亚群。为了研究巨噬细胞异质性在动脉粥样硬化发生中的作用,我们建立了一种用于人单核细胞衍生巨噬细胞的新型分离和培养技术。本技术在分化开始前不选择单核细胞亚群。单核细胞在自体淋巴细胞存在的情况下培养2周,然后进行定量接种。它们在形态、脂质组成和生物活性方面分化为成熟的巨噬细胞。基于吞噬活性以及CD14、CD36和低密度脂蛋白(LDL)受体的表达,我们确定了可能在动脉粥样硬化发生中发挥不同作用的巨噬细胞亚群。虽然几乎所有贴壁纯化的单核细胞都表达CD14、CD36和LDL-R,但我们根据这些抗原的表达对巨噬细胞的三个亚群进行了表征:CD36+CD14-LDL-R-(58±12%)、CD36+CD14+LDL-R+(18±5%),其余细胞为CD36-CD14-LDL-R-。前两个亚群在进一步分化过程中大小减小(分别为51±12%和8±3%)。我们的培养技术也可作为研究巨噬细胞异质性在动脉粥样硬化以外疾病中的影响的良好模型。